We hypothesized that the autotaxin produced by inflamed breast adipocytes adjacent to breast tumors provides a major source of autotaxin secretion that drives breast tumor progression and the loss of treatment efficacy. This evidence concerns the gene ENPP2 and breast neoplasm.